Abstract
Background
Successful parathyroidectomy (PTX) often results in a dramatic drop in the parathyroid hormone (PTH) levels, relieves the patient from clinical symptoms, and reduces mortality. Although PTX is generally a successful treatment for progressive secondary hyperparathyroidism (SHPT) patients subjected to surgery, a significant proportion develops recurrent SHPT following PTX.
Key message
SHPT requiring PTX occurs more commonly in progressive chronic kidney disease and in long-term lithium therapy. Operative approaches include subtotal PTX, total PTX with or without autotransplantation, and possible thymectomy. Each approach has its proponents, advantages, and disadvantages. Although PTX offers the highest percentage cure for SHPT, compared to all other medical and surgical treatment, recurrent hyperparathyroidism can be observed in some patients dependent on follow-up time. A literature review and analysis of recent data regarding how to reduce recurrence of SHPT at the time of primary surgery was performed. The current literature and our own experience in the field have confirmed that pre-operative imaging, thymectomy, stereo magnifier, and surgical procedure may effectively reduce recurrence of SHPT at the time of primary surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fraser WD (2009) Hyperparathyroidism. Lancet 374(9684):145–158
Tominaga Y, Sato K, Tanaka Y et al (1995) Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 44(Suppl 1):S42–S47
Felsenfeld AJ (1997) Considerations for the treatment of secondary hyperparathyroidism in renal failure. J Am Soc Nephrol 8(6):993–1004
Tominaga Y, Tanaka Y (1997) Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13(2):78–86
Schneider R, Slater EP, Karakas E et al (2012) Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg 36(2):318–326
Komaba H, Taniguchi M, Wada A et al (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88(2):350–359
Giordano A, Rubello D, Casara D (2001) New trends in parathyroid scintigraphy. Eur J Nucl Med 28(9):1409–1420
Hindie E, Ugur O, Fuster D et al (2009) 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 36(7):1201–1216
Milas M, Weber CJ (2004) Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery 136(6):1252–1260
Wimmer G, Profanter C, Kovacs P et al (2010) CT–MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism. Langenbecks Arch Surg 395(1):73–80
Hindie E, Urena P, Jeanguillaume C et al (1999) Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 353(9171):2200–2204
Neumann DR, Esselstyn CB Jr, Madera A et al (1998) Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metab 83(11):3867–3871
Krausz Y, Bettman L, Guralnik L et al (2006) Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg 30(1):76–83
Yang J, Hao R, Yuan L et al (2014) Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism. AJR Am J Roentgenol 202(1):180–184
Proye CAG, Carnaille B, Bizard JP et al (1992) Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: where are we in the early 1990s? A plea against unilateral parathyroid exploration. Surgery 112:1118
Chen J, Wang JD (2014) Radioguided parathyroidectomy in patients with secondary hyperparathyroidism due to chronic renal failure. Nucl Med Commun 35(4):391–397
Fuster D, Ybarra J, Ortin J et al (2006) Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging 33(4):467–473
Blackburn CC, Manley NR (2004) Developing a new paradigm for thymus organogenesis. Nat Rev Immunol 4(4):278–289
Maret A, Bourdeau I, Ding C et al (2004) Expression of GCMB by intrathymic parathyroid hormone-secreting adenomas indicates their parathyroid cell origin. J Clin Endocrinol Metab 89(1):8–12
Liu Z, Farley A, Chen L et al (2010) Thymus-associated parathyroid hormone has two cellular origins with distinct endocrine and immunological functions. PLoS Genet 6(12):e1001251
Gunther T, Chen ZF, Kim J et al (2000) Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 406(6792):199–203
Madorin C, Owen RP, Fraser WD et al (2012) The surgical management of renal hyperparathyroidism. Eur Arch Otorhinolaryngol 269(6):1565–1576
Powell AC, Alexander HR, Pingpank JF et al (2008) The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. Surgery 144(6):878–883 (discussion 883–884)
Welch K, McHenry CR (2012) The role of transcervical thymectomy in patients with hyperparathyroidism. Am J Surg 203(3):292–295 (discussion 295–296)
Schlosser K, Endres N, Celik I et al (2007) Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg 31(10):1947–1953
Well SA Jr, Gunnells JC, Shelburne JD et al (1975) Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 78(1):34–44
Tominaga Y, Matsuoka S, Uno N et al (2010) Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg 34(6):1312–1317
He Q, Zhuang D, Zheng L et al (2014) Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience. BMC Surg 14:26
Ogg CS (1967) Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism. Br Med J 4(5575):331–334
Stracke S, Keller F, Steinbach G et al (2009) Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism. Nephron Clin Pract 111(2):c102–c109
Schlosser K, Veit JA, Witte S et al (2007) Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial. Trials 8:22
Tominaga Y, Numano M, Tanaka Y et al (1997) Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13(2):87–96
Neyer U, Hoerandner H, Haid A et al (2002) Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 17(4):625–629
Horandner H, Murzl E, Neyer U et al (2000) Focal proliferation in reactive hyperplastic parathyroid tissue in end-stage renal failure—implication for autotransplantation after total parathyroidectomy. Wien Klin Wochenschr 112(8):353–357
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests or financial interest invested in this work.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Additional information
D. Xu and Y. Yin contributed equally.
Rights and permissions
About this article
Cite this article
Xu, D., Yin, Y., Hou, L. et al. Surgical management of secondary hyperparathyroidism: how to effectively reduce recurrence at the time of primary surgery. J Endocrinol Invest 39, 509–514 (2016). https://doi.org/10.1007/s40618-015-0410-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0410-8